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Acute hematogenous bone and joint infections, septic
arthritis, and osteomyelitis with or without adjacent septic
arthritis, are rare among children in a standard Western
setting, but still potentially devastating diseases, as even
deaths have been reported recently. Foir this reason, and
in part due to historical reasons, the treatment has
comprised of months-long courses of antibiotics, started
intravenously for at least a week, and aggressive surgery.
Recent prospective and randomized trials have shown that
a 2-4-day parenteral course, completed orally to a total
duration of 10-14 days for septic arthritis and of 3 weeks
for osteomyelitis, heals the great majority of cases,
provided large-enough doses of a well-absorbing antibio-
tic, and a four-times-daily (qid) regimen is used. Staphylo-
coccus aureus - the most common causative agent in
osteoarticular infections - is the primary target for treat-
ment. For methicillin-susceptible strains, first-generation
cephalosporins, clindamycin, and staphylococcal penicil-
lins are first-line antibiotics of which clindamycin has
retained activity even for most cases due to methicillin-
resistant S.aureus. This said, instead of clindamycin,
beta-lactam antibiotics are effective also against Kingella
kingae. The role of surgery in uncomplicated cases is
minor, even in cases of shoulder or hirp arthritis, as most
children recover uneventfully with no greater intervention
than diagnostic bone or joint aspiration. Routine arthrot-
omy seems unnecessary even in hip or shoulder arthritis.
However, each patient needs an individual approach, and
a deviation from the general treatment lines should be




1University of Helsinki. 2Infectious Diseases, Helsinki, Finland.
Published: 17 September 2014
doi:10.1186/1546-0096-12-S1-I30
Cite this article as: Peltola: Treatment of septic arthritis and acute
osteomyelitis. Pediatric Rheumatology 2014 12(Suppl 1):I30.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit1University of Helsinki
Full list of author information is available at the end of the article
Peltola Pediatric Rheumatology 2014, 12(Suppl 1):I30
http://www.ped-rheum.com/content/12/S1/I30
© 2014 Peltola; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
